Skip Navigation

Defense Health Agency

"On October 1, 2013, the Department of Defense established the Defense Health Agency (DHA) to manage the activities of the Military Health System. These activities include those previously managed by TRICARE Management Activity (TMA), which was disestablished on the same date. During the next several months, all TMA websites will change to reflect the new DHA. We appreciate your patience during this transition."
Covering
November 2010 DoD P&T Committee Reviews
Dial-in number 1-877-647-1066 (Follow system prompts)
Passcode number 2109312#


Agenda
  1. Attendance
  2. Teleforum Interactive Slide Connection DCO URL: https://connect.dco.dod.mil/r10353714
    Interactive Connection will be available the day of and 15 minutes prior to start of the conference.
  3. Drug Classes - DIABETES: NON-INSULIN: Subclass: Amylin Agonist; DIABETES: NON-INSULIN: Subclass: Alpha-Glucosidase Inhibitors; DIABETES: NON-INSULIN: Subclass: Biguanides; DIABETES: NON-INSULIN: Subclass: Dipeptidyl Peptidase 4 (DPP-4) Inhibitors; DIABETES: NON-INSULIN: Subclass: Glucagon-like peptide-1 (GLP-1) Receptor Agonists; DIABETES: NON-INSULIN: Subclass: Meglitinides; DIABETES: NON-INSULIN: Subclass: Thiazolidinediones
  4. Newly Approved Drugs - HYDROMORPHONE HCL (EXALGO); HYDROMORPHONE HCL, (FIBRICOR); PITAVASTATIN CALCIUM, (LIVALO); MOMETASONE/FORMOTEROL, (DULERA); DOXEPIN HCL, (SILENOR); OLMESARTAN MED/AMLODIPINE/H, (TRIBENZOR); ESTRADIOL VALERATE/DIENOGES, (NATAZIA);
  5. Uniform Formulary Voluntary Agreement for TRICARE Retail Rebates (UF-VARR)
  6. Uniform Formulary blanket Purchase Agreement (BPA)
  7. Quote submission - process, evaluation and requirements
  8. Questions and Answers

Participants - Please mute your telephone if you are not actively participating in the teleconference.

Thank You.